Invasive fungal infections in pediatric bone marrow transplant recipients: Single center experience of 10 years

Bone Marrow Transplantation

Volumn 26, Issue 9, 2000, Pages 999-1004

  Hovi, L ^a   Saarinen Pihkala, U M ^b   Vettenranta, K ^a   Saxen, H ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

Bone marrow transplant; Children; Invasive fungal infection; Surveillance cultures

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; AZATHIOPRINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; ITRACONAZOLE; KETOCONAZOLE; MELPHALAN; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; THALIDOMIDE;

ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; ASPERGILLUS; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANDIDA; CANDIDIASIS; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; FUNGUS CULTURE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFANT; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MORTALITY; MYCOSIS; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033757977     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702654     Document Type: Article

References (22)

1. Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation
2. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation
3. Hepatosplenic candidiasis in patients with acute leukemia: Incidence and prognostic implications
4. Candida infections in bone marrow transplant recipients
5. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients
6. Non-Candida fungal infections after bone marrow transplantation: Risk factors and outcome
7. Autopsy-identified infections among bone marrow transplant recipients: A clinico-pathologic study of 56 patients
8. Does ketokonazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo-controlled trial
9. Deep Candida infection in children receiving allogeneic bone marrow transplants: Incidence, risk factors and diagnosis
10. Allogeneic bone marrow transplantation in children: Single institution experience from 1974 to 1992
11. Opportunistic osteomyelitis in the jaws of children on immunosuppressive chemotherapy
12. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis
13. Detection and identification of fungal pathogens in blood by using molecular probes
14. Molecular diagnosis of Candida infection in the compromised host: Current status and future prospects
15. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation
16. Surveillance cultures in bone marrow transplant recipients: Worthwhile or wasteful?
17. Retrospective analysis of yeast colonization and infections in paediatric bone marrow transplant recipients
18. Fungal infections after hematopoietic cell transplantation
19. Risk factors for fungal infection in patients with malignant hematologic disorders: Implications for empirical therapy and prophylaxis
20. Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients
21. Prediction of systemic fungal infection in allogeneic marrow recipients: Impact of amphotericin prophylaxis in high-risk patients